Anthropic’s Claude agents outperformed human researchers and produced “alien science,” raising new questions about AI ...

Nvidia Corporation reported blowout earnings and guided well above consensus, yet NVDA stock dropped roughly 12%, proving sentiment leads fundamentals rather than the other way around. The B wave ...

Dr. Nahm was a White House economist in the Biden administration. Tesla’s factory in Shanghai produces far more cars per worker than its plant in California. The gap reflects something unsettling ...

Pre-serialize complex nested structures before passing to the SDK The real fix would be making the recursive transform async or using an iterative approach. Would be happy to help test a PR if the ...

Exclamation marks, ellipses and ‘haha’ can’t fix our growing inability to communicate. By Nitsuh Abebe “How Many Exclamation Points Are Too Many in an Email? A Psychologist Weighs In.” A psychologist!

When sixteen-year-old Adam Raine told his AI companion that he wanted to die, the chatbot didn’t call for help—it validated his desire: “You don’t want to die because you’re weak. You want to die ...

Imre Szenttornyay, CEO of Cielo IT LLC, empowers business owners to scale their operations profitably with AI-powered SmartSigns technology. When you manage a network of retail or franchise locations, ...

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Recursion Pharmaceuticals, Inc. before investing. In this article, we go over a ...

Recursion, which is backed by Nvidia, may be seeing some extra attention on Wednesday as OpenAI and Anthropic explore data partnerships with biotechs, according to a report from The Information. The ...

The clinical-stage biotech might have a successful drug on its hands, if a relatively early-stage clinical trial is any indication. Its REC-4881 did very well in the testing. 10 stocks we like better ...